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Conclusions Similar to chronic lead exposure, subchronic 
exposure to lead is associated with elevated blood levels 
of uric acid and bilirubin in humans. This probably results 
in increased TAC value despite thiol depletion. However, 
the compensatory activation of non-enzymatic antioxidant 
defenses seems to be insufficient to protect against lead-
induced oxidative stress, which may be additively enhanced 
by the pro-inflammatory action of chemokines, especially 
IL-8.
Keywords Subchronic exposure to lead · Chronic 
exposure to lead · Non-enzymatic antioxidants · Uric acid · 
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Introduction
Lead is a heavy metal, which has been widely used for dec-
ades in paint, gasoline, water pipes, storage batteries, and 
many other products (Lin et al. 2015). In the last decades, 
our view on lead toxicity has changed, giving more con-
cern to exposures, previously considered safe. Lead can 
induce many adverse health effects on various body sys-
tems including the nervous, hematological, immune, and 
genitourinary systems. Nevertheless, due to its malleability, 
resistance to corrosion, and low melting point, lead is still 
widely used in many industries (Wang et al. 2012).
Ingestion and inhalation are the primary routes of lead 
entering the body. After absorption, lead is distributed 
through the bloodstream to various organs, such as brain, 
liver, and kidneys (Alya et al. 2015). It has been proposed 
that kidneys play an important role in the toxicokinetics of 
lead because they serve as the major organ responsible for 
its excretion. Therefore, kidneys are particularly exposed 
to lead toxicity. Lead primarily impairs the function and 
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structure of the renal tubules. Renal tubular epithelial cell 
necrosis, leukocyte infiltration, and tubular epithelial cell 
pyknosis have been shown to be induced by lead toxic-
ity. Many studies indicated that long‐term exposure to 
lead increases the risk of nephropathy, which manifests as 
increased levels of renal dysfunction biomarkers, such as 
plasma creatinine and uric acid (Alya et al. 2015; Liu et al. 
2012).
Several mechanisms have been proposed to explain 
lead-induced toxicity. One of them implicated oxidative 
stress as the underlying mechanism of toxicity (Wang et al. 
2012). Oxidative stress results from imbalance between 
the generation and utilization of reactive oxygen species 
(ROS). Lead ions have been shown to be associated with 
increased generation of ROS. Besides, lead is able to dys-
regulate the antioxidant defenses, including the antioxidant 
enzymes and the non-enzymatic antioxidants, such as uric 
acid. (Dobrakowski et al. 2014; Soliman et al. 2015; Wang 
et al. 2012). In our previous study, we reported higher 
levels of uric acid in workers chronically exposed to lead 
compounds (Blood lead (PbB) = 40.40 ± 10.05 µg/dl) for, 
on average, 16.40 ± 10.20 years compared to the unex-
posed control group (PbB = 6.39 ± 2.47 µg/dl). Besides, 
we reported increased levels of other non-enzymatic anti-
oxidants, such as bilirubin, albumin, thiol groups, and 
α-tocopherol (Dobrakowski et al. 2014). However, the 
possible association between lead toxicity and the non-
enzymatic antioxidant defenses is not fully understood and 
needs further investigation.
Negative effects of lead on human health may be also 
due to its impact on the immune system function. It has 
been shown that lead impairs the function of lympho-
cytes and cytokine production. Some studies indicate 
lead-induced shift in the balance of T-helper (Th) lym-
phocyte function toward Th2-mediated immune response 
at the expense of Th1-mediated response (García-Lestón 
et al. 2012; Hsiao et al. 2011). Besides, lead exerts pro-
inflammatory properties. In experimental and human stud-
ies, lead exposure has been shown to induce expression 
of pro-inflammatory cytokines, such as tumor necrosis 
factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-1β 
(IL-1β) via activation of mitogen-activated protein kinases 
(MAPKs) and nuclear factor kappa B (NF-κB) (Liu et al. 
2012). Both MAPKs and NF-κB can be induced synergisti-
cally by uric acid (Kanellis et al. 2003; Liang et al. 2015). 
Moreover, uric acid exerts its pro-inflammatory action via 
increasing the levels of chemokines, such as interleukin-8 
(IL-8), monocyte chemoattractant protein-1 (MCP-1), and 
RANTES (regulated on activation, normal T cell expressed 
and secreted) (Liang et al. 2015; Zhou et al. 2012). Simi-
larly, lead has been shown to induce interleukin-8 (IL-8), a 
potent chemokine (Lin et al. 2015; Yang et al. 2014).
Up-to-date studies indicate lead-induced dysregula-
tion of the immune response in humans. However, in the 
available literature, there are no conclusive epidemiologi-
cal studies regarding the immunotoxic effects of lead in 
occupationally exposed workers. Similarly to mechanisms 
underlying the associations between lead and the non-enzy-
matic antioxidant defense, the exact mechanisms of lead 
interactions with the immune system in humans still remain 
unclear (García-Lestón et al. 2012). Some authors postulate 
that the influence of lead on the immune response is dose-
dependent (Hsiao et al. 2011; Iavicoli et al. 2006). Duration 
of exposure seems to be the second factor modifying inter-
actions of lead with the immune system. In light of this, we 
decided to examine workers subchronically and chronically 
exposed to lead. We focused on the influence of lead on the 
non-enzymatic antioxidant defenses, including uric acid, 
and chemokine levels, which may be related to the immu-
nomodulatory properties of both lead and uric acid.
Materials and methods
Study population
Each study subject provided a written consent to a study. 
Questionnaire data on age, weight, height, medical history, 
and smoking were obtained. The levels of lead and zinc 
protoporphyrin in the blood served as biomarkers of lead 
exposure.
The study population was divided into three groups. The 
first group consisted of 34 male workers subchronically 
exposed to lead for 36–44 days, aged from 22 to 61 years. 
Subjects in this group worked in lead–zinc works to per-
form periodic maintenance of blast furnaces and produc-
tion lines. Among the exposed population, 17 workers were 
occupationally exposed to lead for the first time, while the 
other 17 workers had a history of occupational exposure to 
this xenobiotic. Workers were subjected to high doses of 
lead because they did not adhere to the occupational safety 
and health precautions and did not properly use personal 
protective equipment.
The second group included 52 male workers chronically 
exposed to lead for a maximum of 38 years, aged from 23 
to 55 years. Workers in that group worked in lead–zinc 
works as smelters, fitters, and production masters.
The third group was a control group, which included 22 
male administrative employees aged from 26 to 59 years. 
Their blood lead levels were below 10 μg/dl. None of the 
subjects in this group was occupationally exposed to lead.
Exclusion criteria included history of any chronic dis-
eases (such as immune disorders, diabetes, arterial hyper-
tension, coronary artery disease, and malignant neoplasm) 
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and abnormal physical examination findings, especially 
symptoms and signs of any infectious diseases.
The experimental setup has been approved by the Bio-




Blood was drawn once from workers chronically exposed 
to lead and from subjects in the control group. However, 
blood was drawn twice from workers subchronically 
exposed to lead, at the beginning of the study and after a 
period of subchronic exposure to lead.
Blood samples obtained from each subject were taken 
from the cubital vein using vacuum tubes (Vacuette®; 
Greiner-Bio, Frickenhausen, Germany) that contained 
K3EDTA to obtain whole blood or using plain tubes to 
obtain serum. Blood samples were frozen and stored at 
−20 °C until used.
Determination of lead concentration
PbB assessments were performed by graphite furnace 
atomic absorption spectrometry using ICE 3400 instru-
ment (Thermo Fisher Scientific Waltham, MA, USA). The 
laboratory met the requirements of proficiency tests (Lead 
and Multielement Proficiency—CDC in Atlanta). Clin-
Cal® Whole Blood Calibrator and ClinCal® Serum Cali-
brator (Recipe, Germany) were used for calibration of the 
instrument and control materials. ClinCheck Whole Blood 
Control Levels I, II, and III, and ClinCheck Serum Control 
Levels I and II were used for quality control. Data were 
expressed as µg/dl.
Determination of zinc protoporphyrin concentration
The blood concentration of zinc protoporphyrin (ZPP) 
was measured directly using Aviv Biomedical hemato-
fluorometer model 206, using an excitation wavelength of 
415 nm and an emission wavelength of 596 nm. The instru-
ment measures the ratio of ZPP fluorescence to the sam-
ple (hemoglobin) absorption, displayed as μg ZPP per g of 
hemoglobin (μg/g Hb). The concentration of hemoglobin 
in 10 % hemolysate was determined by the cyanmethemo-
globin method using Drabkin’s reagent.
Determination of uric acid, bilirubin, and albumin 
concentrations
The serum concentrations of uric acid, albumin, and bili-
rubin were measured using PerkinElmer biochemical 
analyzer according to the manufacturer’s instructions. Uric 
acid and bilirubin concentrations were expressed as mg/dl, 
while those for albumin were expressed as g/l.
Determination of total thiols
The concentration of thiol groups in serum was determined 
as described by Koster et al. (1986) using 5,5′-dithiobis-
(2-nitrobenzoic acid) (DTNB), which undergoes reduc-
tion by compounds containing sulfhydryl groups, yielding 
the yellow anion derivative, 5-thio-2-nitrobenzoate, which 
absorbs light at a wavelength of 412 nm. This assay was 
carried out using an automated analyzer PerkinElmer. The 
results were expressed as μmol per g of protein (P).
Determination of total antioxidant capacity (TAC)
Total antioxidant capacity was measured in serum accord-
ing to Erel (2004). In this colorimetric method, radicals 
are generated and the antioxidant ability of seminal plasma 
reduces radical formation. The change in color of ABTS 
ions (2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonate) 
is measured as the change in absorbance at 660 nm. This 
assay was conducted in an automated PerkinElmer analyzer 
calibrated with Trolox. Data were expressed as mmol/l.
Determination of total oxidant status (TOS)
Total oxidant status was measured in serum according to 
Erel (2005). The assay is based on the oxidation of fer-
rous ions to ferric ions in the presence of various oxidiz-
ing agents in acidic medium. The color change of xylenol 
orange by ferric ions is measured as the change in absorb-
ance at 560 nm. This assay was conducted in an automated 
analyzer (PerkinElmer) calibrated with hydrogen peroxide. 
Data were expressed as µmol/l.
Oxidative stress index (OSI)
The percentage ratio of TOS to TAC was used as an OSI.
Determination of chemokines
The levels of interleukin-8 (IL-8), eotaxin, interferon 
gamma-induced protein-10 (IP-10), MCP-1, macrophage 
inflammatory protein-1β (MIP-1β), and RANTES were 
determined in serum using a Bio-Plex 200 System (Bio-
Rad Laboratories Inc., USA).
The Bio-Plex system is based on three core elements. 
The first core element is a technology that uses fluores-
cent magnetic microspheres (beads), each with a distinct 
color code to permit discrimination of individual tests 
within a multiplex suspension and allow the simultaneous 
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detection of diverse analyte molecules in each single well 
of a 96-well microplate. Moreover, the magnetic beads 
allow for magnetic separation during the washing steps. 
The second core element is a specific flow cytometer with 
two lasers and associated optics to measure different mol-
ecules bound to the surface of the beads. The third core ele-
ment is a high-speed digital signal processor that efficiently 
analyzes the fluorescent output.
The principle of these bead-based assays is similar to 
that of capture-sandwich immunoassays. The samples and 
standards were incubated with the antibody-coupled beads 
(antibodies directed against the desired cytokines were 
covalently coupled to internally dyed beads) in 96-well 
plates and washed. Next, the biotinylated detection anti-
bodies specific for different cytokine epitopes were added. 
After incubation and washing, streptavidin (phycoerythrin 
solution) was added to bind to the biotinylated detection 
antibodies on the beads. The suspensions of the washed 
beads were analyzed using the Bio-Plex System. The soft-
ware presented the data as both median fluorescence inten-
sity and concentration (pg/ml).
Statistical analysis
The statistical analysis was performed using Statis-
tica 9.1 PL software program. Data were expressed as 
mean ± standard deviation (SD) for normally distributed 
data and in terms of median and interquartile range (IQR) 
for non-normally distributed data. Shapiro–Wilk’s test was 
used to verify normality, and Levene’s test was used to ver-
ify the homogeneity of variances. Statistical comparisons 
were made using t test, t test with separate variance esti-
mates, Mann–Whitney U test, or Chi-squared test. Depend-
ent variables were analyzed using Student’s t test and Wil-
coxon’s test.
To compare the values of the measured cytokines in 
workers subchronically exposed to lead and those chron-
ically exposed to lead, the levels of each cytokine in 
both groups were normalized. Values of cytokine levels 
measured in workers after subchronic exposure to lead 
were normalized to the median of the values obtained 
before exposure, while values of cytokine levels meas-
ured in chronically lead-exposed workers were normal-
ized to the median of the values obtained from the con-
trol group.
Additionally, regression analysis was performed. The 
results of each parameter are not normally distributed. In 
order to obtain normal distributions, the values were log-
transformed. However, we obtained a distribution, which 
enabled us to use multiple regression analyses only for 
IP-10, MIP-1β, and IL-8. In multiple regression, we ana-
lyzed the effects of blood lead level, BMI, age, and smok-
ing on IP-10, MIP-1β, and IL-8 concentrations. Since 
cytokines concentrations differed significantly between the 
subchronically exposed group and the chronically exposed 
group, the group encoding the variable was introduced into 
the regression equation. A p value < 0.05 was considered to 
be significant.
Results
Epidemiologic data and blood lead concentrations are pre-
sented in Tables 1 and 2.  
The levels of uric acid and bilirubin were significantly 
higher after a subchronic exposure to lead compared to 
the baseline by 22 and 35 %, respectively. Similarly, the 
values of TAC, TOS, and OSI increased by 15, 50, and 
33 %, respectively. At the same time, the levels of thiol 
group and albumin decreased by 5 and 8 %, respectively 
(Table 3). The levels of IL-8 and MIP-1β were significantly 
higher after a subchronic exposure to lead compared to the 
baseline by 34 and 20 %, respectively, while the levels of 
Table 1  Epidemiologic data and lead exposure markers in the group 
of workers subchronically exposed to lead (n = 34)
PbB blood lead level; ZPP zinc protoporphyrin level in the blood
Mean SD
Age (years) 40 13
Exposure duration (days) 40 3
Weight (kg) 79.3 12.5
Height (cm) 176 6.71
Smokers (%) 68 % –
PbB before exposure to lead (µg/dl) 10.7 7.83
PbB after exposure to lead (µg/dl) 48.7 14.2
ZPP (μg/g Hb) 2.66 0.64
Table 2  Epidemiologic data and lead exposure markers in the group 
of workers chronically exposed to lead and in the control group
PbB blood lead level; ZPP zinc protoporphyrin level in the blood; p 




Control group n = 22
Mean SD Mean SD p
Age (years) 39 8 41 8 0.224
Years of work 13 10 17 9 0.128
Height (cm) 177 5.58 179 8.03 0.112
Weight (kg) 84.2 14.1 88.9 12.2 0.176
Smokers (%) 37 % – 32 % – 0.702*
PbB (µg/dl) 36.6 8.60 2.22 1.42 <0.001
ZPP (μg/g Hb) 4.24 1.82 2.38 0.61 <0.001
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eotaxin, IP-10, MCP-1, and RANTES did not change after 
a subchronic exposure to lead (Table 4).
The level of IL-8 was significantly higher in the group 
of workers chronically exposed to lead than in the control 
group by 40 %, while the level of IP-10 was significantly 
lower by 28 %. The levels of the remaining chemokines did 
not differ between both groups (Table 5).
Multiple regression analysis showed that the duration of 
lead exposure (subchronic vs. chronic) affects IP-10 and 
MIP-1β concentrations. Besides, the BMI, age, and smok-
ing habits did not significantly affect the levels of those 
cytokines. In consistence with these results, comparisons 
made between the medians of the normalized cytokine lev-
els in subchronically and chronically lead-exposed groups 
showed significant differences in the normalized values of 
IP-10, MCP-1, and MIP-1β levels between the two groups 
(Table 6).
Discussion
Results of the present study showed that subchronic expo-
sure to lead is able to increase uric acid level in the blood. 
However, increased uric acid level may be not only due 
Table 3  Levels of uric acid, 
thiol groups, albumin, and 
bilirubin and values of total 
antioxidant capacity (TAC), 
total antioxidant status (TOS), 
and oxidative stress index (OSI) 
before and after subchronic 
exposure to lead, p value–t test 
for dependent variables, p* 
value–Wilcoxon’s test
Before exposure After exposure Relative 
change (%)
p value
Mean SD Mean SD
Uric acid (mg/dl) 6.23 1.00 7.57 1.88 22 <0.001
Thiol groups (µmol/g P) 3.89 0.45 3.68 0.64 −5 0.022
Albumin (g/l) 6.62 0.93 6.07 1.05 −8 0.013
Bilirubin (mg/dl) 0.45 0.24 0.60 0.51 35 0.027*
TAC (mmol/l) 0.76 0.10 0.87 0.14 15 <0.001
TOS (µmol/l) 9.99 7.20 14.9 10.6 50 0.008*
OSI (%) 1.35 0.98 1.79 1.32 33 0.022*
Table 4  Levels of interleukin-8 (IL-8), eotaxin, interferon gamma-
induced protein-10 (IP-10), monocyte chemoattractant protein-1 
(MCP-1), macrophage inflammatory protein-1β (MIP-1β), and 
RANTES (regulated on activation, normal T cell expressed and 
secreted) before and after subchronic exposure to lead showed as a 
median and interquartile range (IQR), p value–Wilcoxon’s test
Before exposure After exposure Relative change (%) p value
Median IQR Median IQR
IL-8 (pg/ml) 4.30 3.53 5.77 6.37 34 0.047
Eotaxin (pg/ml) 93.0 87.1 106 66.9 14 0.437
IP-10 (pg/ml) 751 713 1052 795 40 0.074
MCP-1 (pg/ml) 33.5 29.9 27.7 38.7 −17 0.248
MIP-1β (pg/ml) 51.7 30.8 62.1 43.7 20 0.002
RANTES (pg/ml) 21,431 3305 20,434 3309 −5 0.174
Table 5  Levels of interleukin-8 (IL-8), eotaxin, interferon gamma-
induced protein-10 (IP-10), monocyte chemoattractant protein-1 
(MCP-1), macrophage inflammatory protein-1β (MIP-1β), and 
RANTES (regulated on activation, normal T cell expressed and 
secreted) in the group of workers chronically exposed to lead and in 
the control group showed as a median and interquartile range (IQR), 
p value–Mann–Whitney U test
Control group Chronic lead-exposed group Relative change (%) p value
Median IQR Median IQR
IL-8 (pg/ml) 2.11 0.50 2.95 0.90 40 <0.001
Eotaxin (pg/ml) 95.3 54.6 119 76.7 25 0.083
IP-10 (pg/ml) 1237 676 887 552 −28 0.036
MCP-1 (pg/ml) 14.6 9.01 15.3 14.2 5 0.178
MIP-1β (pg/ml) 65.4 29.8 58.2 28.2 −11 0.197
RANTES (pg/ml) 21,607 1576 20,752 2059 −4 0.109
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to the subclinical renal function impairment but also due 
to altered purine metabolism. In our previous study, we 
showed a positive association between lead exposure and 
the activity of xanthine oxidase, which is responsible for 
uric acid formation from purines being degraded (Kasper-
czyk et al. 2013). In consistence with these results, posi-
tive correlations between blood lead levels and uric acid 
concentrations were observed by Hernández-Serrato et al. 
(2006) in subjects environmentally exposed to high doses 
of lead and by Wang et al. (2002) and Ehrlich et al. (1998) 
in battery factory workers. Besides, Khan et al. (2008) 
reported an increased uric acid level in a group of chroni-
cally lead-exposed workers (PbB = 29.1 μg/dl). Similarly, 
a study on workers chronically exposed to high doses of 
lead reported same results (PbB = 80.9 μg/dl). However, 
there are human studies showing no association between 
lead exposure and uric acid levels (Konishi et al. 1994; 
Roels et al. 1994).
Uric acid acts as a scavenger of ROS and serves as a 
main antioxidant in human plasma (Gersch et al. 2008). 
Therefore, the elevation of uric acid level may compen-
sate for the simultaneous decrease in thiol group level. As 
a result, the TAC value was paradoxically increased due to 
subchronic lead exposure. However, uric acid has also been 
shown to act as a pro-oxidant. Uric acid is able to react 
directly with nitric oxide (NO) to form 6-aminouracil. This 
irreversible reaction, resulting in depletion of NO, can be 
partially blocked by glutathione (GSH). Therefore, under 
oxidative stress conditions, when the GSH pool is depleted, 
uric acid may induce endothelial dysfunction (Gersch et al. 
2008; Xie et al. 2015). It is well documented that lead 
exposure induces GSH depletion (Kasperczyk et al. 2014). 
In light of this, the role of uric acid in the defense against 
lead toxicity can be divergent and may depend on the spe-
cific redox conditions of the particular microenvironment. 
What makes this issue more complicated is that uric acid 
also exerts pro-inflammatory properties (Hayden and Tyagi 
2004).
In in vitro studies, both lead and uric acid have been 
reported to induce the expression of IL-8 via MAPKs and 
NF-κB signaling pathways (Lin et al. 2015; Liang et al. 
2015). IL-8 is secreted by multiple cell types in response to 
pro-inflammatory stimuli and serves as a strong chemotac-
tic agent for neutrophils. Neutrophils may cause oxidative 
damage to tissues. Consequently, IL-8 may be involved in 
many inflammatory diseases, such as rheumatoid arthritis, 
gouty arthritis, asthma, and acute respiratory distress syn-
drome. Besides, experimental studies showed that IL-8 
plays a role in promotion of angiogenesis and metastasis 
(Lin et al. 2015; Yan et al. 2015). Since this study showed 
elevated level of IL-8 due to both subchronic and chronic 
lead exposure, then IL-8 may also display negative effects 
in humans exposed to lead toxicity.
Similarly, MCP-1 expression and level have been shown 
to be increased by lead and uric acid through MAPKs and 
NF-κB signaling pathways in in vitro and experimental 
studies (Kanellis et al. 2003; Kumawat et al. 2014; Liang 
et al. 2015; Soliman et al. 2015; Zhou et al. 2012). In addi-
tion, uric acid has been reported to increase the expression 
and levels of RANTES in vitro (Zhou et al. 2012). MCP-1 
is released due to pro-inflammatory stimuli and displays 
a chemoattractive activity on monocytes, basophils, and 
lymphocytes, thus plays a role in the allergic reactions 
(Luster and Rothenberg 1997). RANTES also belongs to 
the chemokine family and is responsible for recruiting a 
variety of leukocytes into the inflammation sites, such as 
lymphocytes, macrophages, eosinophils, and basophils 
(Aldinucci and Colombatti 2014). Levels of both MCP-1 
and RANTES were not significantly affected by subchronic 
and chronic exposure to lead. However, a comparison made 
between the normalized values of MCP-1 in subchroni-
cally and chronically lead-exposed workers showed that 
the influence of lead on MCP-1 level might be opposite 
depending on the exposure period.
As in the case of MCP-1 and RANTES, the present study 
did not confirm the influence of lead exposure on eotaxin 
level. Eotaxin acts as a chemokine-stimulating eosinophils 
chemotaxis. Besides, eotaxin induces the release of eosin-
ophils from the bone marrow, their aggregation, and their 
respiratory burst activity (Rankin et al. 2000).
Results of the present study indicated that a subchronic 
exposure to lead, apart from increasing the level of IL-8, 
might induce inflammation via increasing the level of 
MIP-1β, a member of the MIP-1 family, which orches-
trates acute and chronic inflammatory host responses by 
recruiting pro-inflammatory cells, especially lymphocytes 
Table 6  Normalized cytokine levels obtained from subchronically 
and chronically lead-exposed groups showed as a median and inter-
quartile range (IQR), p value–Mann–Whitney U test
a Median of the values of cytokine levels measured in workers after 
subchronic exposure to lead that were normalized to the median of 
the values obtained before exposure
b Median of the values of cytokine levels measured in chronically 
lead-exposed workers that were normalized to the median of the val-
ues obtained from the control group
Subchronic  




Mediana IQR Medianb IQR
IL-8 (%) 134 80–229 140 114–157 0.980
Eotaxin (%) 114 66–138 125 87–168 0.180
IP-10 (%) 140 83–189 72 55–100 <0.001
MCP-1 (%) 83 32–148 105 79–176 0.007
MIP-1β (%) 120 96–181 89 70–114 <0.001
RANTES (%) 95 95–101 96 91–101 0.660
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and monocytes (Maurer and von Stebut 2004). Chronic 
exposure to lead did not significantly affect the level of 
MIP-1β but influenced the level of IP-10, which serves as 
a chemokine as well. The level of IP-10 was significantly 
lower in chronically lead-exposed workers than in the con-
trol group. The secretion of IP-10 by lymphocytes depends 
on IFN-γ level and is related to the Th1-mediated immune 
response (Antonelli et al. 2014). Therefore, a decrease in 
IP-10 level due to chronic lead exposure may be caused by 
lead-induced skewing toward the Th2-mediated immune 
response as postulated in some experimental studies (Heo 
et al. 2007; 1996; Hsiao et al. 2011). Besides, it has been 
postulated that uric acid is also able to trigger the Th2-
mediated immune response (Moon et al. 2010). Addition-
ally, multiple regression analysis and comparisons made 
between the normalized values of IP-10 and MIP-1β in 
subchronically and chronically lead-exposed workers con-
firmed that the influence of lead on their levels is divergent 
in those two different types of exposures. Iavicoli et al. 
(2006) showed that the effect of lead exposure on cytokine 
levels in mice depends on the blood lead level. However, 
results of the present study indicate that lead may affect 
cytokine levels in different ways depending on the expo-
sure duration rather than blood lead level.
In our previous study on chronically lead-exposed work-
ers, we reported not only a higher level of uric acid but 
also a higher bilirubin level. In addition, the present study 
showed an increased level of bilirubin due to subchronic 
exposure to lead. Bilirubin is the end product of heme deg-
radation. Heme is converted by heme oxygenase (HO) to 
biliverdin, which is in turn reduced to bilirubin by biliver-
din reductase. Bilirubin has been shown to have a strong 
antioxidant potential against peroxyl radicals; however, 
it could also exert toxic effects when present in excess 
(Fuhua et al. 2012; Annabi Berrahal et al. 2007). Several 
animal studies on rats showed elevated bilirubin levels as a 
result of lead exposure (Abdel-Moneim et al. 2011; Annabi 
Berrahal et al. 2007; Ibrahim et al. 2011). Such elevation 
of bilirubin level may be beneficial owing to its antioxidant 
properties. In accordance with this, Noriega et al. (2003) 
showed that bilirubin administration to rats increased GSH 
level, enhanced the activity of antioxidant enzymes, and 
decreased the toxicity induced by δ-aminolevulinic acid 
(ALA). ALA accumulates because of the lead-induced 
inhibition of δ-aminolevulinic acid dehydratase (ALAD) 
(Wang et al. 2015). Therefore, high bilirubin level may 
contribute to the elevation of the TAC value. On the other 
hand, results of human studies on the role of bilirubin in 
lead toxicity are not as conclusive as those of the experi-
mental studies. Al-Neamy et al. (2001) and Khan et al. 
(2008) did not report any significant association between 
bilirubin level and chronic lead exposure in male work-
ers. The negative results of these studies may be due to the 
complexity of the possible interactions between lead and 
heme metabolism. On the one hand, it is well documented 
that lead inhibits heme biosynthesis (Dobrakowski et al. 
2014). Consequently, the depletion of the heme pool may 
result in its decreased degradation and less bilirubin synthe-
sis. On the other hand, lead may induce heme degradation 
via induction of the inducible isoform of heme oxygenase 
(HO-1) (Vargas et al. 2003). Lead may also increase heme 
degradation via induction of eryptosis (Aguilar-Dorado 
et al. 2014).
In contrast to uric acid and bilirubin levels, the level of 
albumin significantly decreased after a subchronic expo-
sure to lead compared to the baseline. Similarly, in our 
previous study, we reported lower albumin level in chroni-
cally lead-exposed workers when compared to the control 
group. In consistence with our results, Khan et al. (2008) 
reported decreased serum albumin and total protein lev-
els in lead-exposed industrial workers. Koo et al. (1994) 
reported decreased albumin mRNA level in rat liver due to 
lead nitrate administration. This experimental study further 
supports the results of the human studies.
Albumin is the most abundant plasma protein, which 
serves to buffer the blood, maintain the osmotic pressure, 
and as a carrier of many compounds (Guo et al. 2014). 
Because of their ROS scavenging activity, thiol groups of 
cysteine residues of albumin determine the plasma redox 
status (Dobrakowski et al. 2014). Therefore, decreased 
level of thiol groups, observed in the present study may 
be secondary to the decrease in albumin level. The second 
possible explanation for the reduced thiol group level is the 
well-documented high affinity of lead toward thiol groups 
(Dobrakowski et al. 2014). In accordance with the human 
studies, decreased level of thiol groups was also reported in 
experimental studies in rats (El-Missiry 2000; Tandon et al. 
2002). Our previous study on chronically lead-exposed 
workers also showed decreased thiol group level (Dobra-
kowski et al. 2014). Interactions between lead and thiol 
groups may also influence the immune response because it 
has been proposed that lead may affect lymphocyte func-
tions due to its high affinity for the sulfhydryl groups on 
T-lymphocyte surface receptors. As a result, antigen pro-
cessing from monocytes to T lymphocytes may be impaired 
(García-Lestón et al. 2012).
The development of oxidative stress in chronic lead 
exposure is well established (Kasperczyk et al. 2014). The 
decrease in thiol group level and the elevation of TOS and 
OSI values observed in the present study confirm that a 
subchronic exposure to lead is also able to induce oxidative 
stress despite increased TAC value.
The results of this study need to be evaluated within the 
context of its limitations. A major limitation was a limited 
groups’ size. Besides, the possible confounding role of 
other pollutants was not taken into consideration.
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Conclusions
Similar to chronic lead exposure, subchronic exposure to 
lead modifies the blood levels of uric acid, thiol groups, 
bilirubin, and albumin in humans. Modifications of uric 
acid and bilirubin levels may be related to the non-enzy-
matic antioxidant defense mechanisms against lead toxicity 
and result in increased TAC value. However, this elevation 
seems to be insufficient to protect against lipid peroxidation 
and to compensate for thiol depletion. In both subchronic 
and chronic lead exposures, oxidative stress may be 
enhanced by the pro-inflammatory action of chemokines, 
especially IL-8. Besides, lead may affect IP-10, MCP-
1, and MIP-1β levels in different ways depending on the 
exposure duration rather than blood lead level. These 
results indicate a need to investigate the mechanisms of 
human adaptation to lead toxicity related to the exposure 
period.
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